orelabrutinib
Modify Date: 2025-08-22 10:51:42
orelabrutinib structure
|
Common Name | orelabrutinib | ||
|---|---|---|---|---|
| CAS Number | 1655504-04-3 | Molecular Weight | 427.50 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C26H25N3O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of orelabrutinibOrelabrutinib (ICP-022) is a potent, orally active, and irreversible Bruton's tyrosine kinase (BTK) inhibitor. Orelabrutinib has the potential for B-cell malignancies treatment[1]. |
| Name | Orelabrutinib |
|---|
| Description | Orelabrutinib (ICP-022) is a potent, orally active, and irreversible Bruton's tyrosine kinase (BTK) inhibitor. Orelabrutinib has the potential for B-cell malignancies treatment[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C26H25N3O3 |
|---|---|
| Molecular Weight | 427.50 |
| InChIKey | MZPVEMOYADUARK-UHFFFAOYSA-N |
| SMILES | C=CC(=O)N1CCC(c2ccc(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)n2)CC1 |